On ECHEMI
Home > Drugs > Bikang Pharmaceutical Xinyi Group Holdings Co., Ltd.
Bikang Pharmaceutical Xinyi Group Holdings Co., Ltd.
  • Founded in:

    2001-06-28
  • Country:

    China China
  • Address:

    South of Ma Lingshan West Road and west of Gansu Road, Xinyi Economic and Technological Development Zone
  • Tax NO.:

    913203817287243869
  • Registered Funds:

    348 million yuan
  • Email:

Related Drugs
Tinidazole and Glucose Injection
The main ingredient of this product is tinidazole. Its chemical name is 2-methyl-1-[2-(ethylsulfonyl)ethyl]-5-nitro-1H-imidazole. Molecular formula: C8H13N3O4S Molecular weight: 247.28
Name Description Content CAS NO. Registered Holders
Tinidazole

It has high activity against protozoa and anaerobic bacteria and can inhibit most anaerobic bacteria; microaerophilic bacteria and Helicobacter pylori are sensitive to it; its anti-amoeba mechanism is to inhibit its redox reaction, causing the protozoa's nitrogen chain to break, thereby killing the protozoa.

More

It has high activity against protozoa and anaerobic bacteria and can inhibit most anaerobic bacteria; microaerophilic bacteria and Helicobacter pylori are sensitive to it; its anti-amoeba mechanism is to inhibit its redox reaction, causing the protozoa's nitrogen chain to break, thereby killing the protozoa.

19387-91-8 12
Tinidazole and Glucose Injection
The main ingredient of this product is tinidazole, chemical name: 1-[2-(ethylsulfonyl)ethyl]-2-methylimidazole.
Name Description Content CAS NO. Registered Holders
Tinidazole

It has antiprotozoan and obligate anaerobic effects. It has inhibitory effects on protozoa such as Trichomonas vaginalis, Entamoeba histolytica and Giardia lamblia. It has antibacterial effects on most anaerobic bacteria such as Bacteroides fragilis, Bacteroides melanin, other Bacteroides, Clostridium, Eubacteria, Fusobacterium, Haemophilus vaginalis, Peptococcus, Peptostreptococcus and Veillonella.

More

It has antiprotozoan and obligate anaerobic effects. It has inhibitory effects on protozoa such as Trichomonas vaginalis, Entamoeba histolytica and Giardia lamblia. It has antibacterial effects on most anaerobic bacteria such as Bacteroides fragilis, Bacteroides melanin, other Bacteroides, Clostridium, Eubacteria, Fusobacterium, Haemophilus vaginalis, Peptococcus, Peptostreptococcus and Veillonella.

19387-91-8 12
Isatis root injection
Isatis root.
Name Description Content CAS NO. Registered Holders
Isatidis Radix

0
Betahistine Hydrochloride and Sodium Chloride Injection
Betahistine hydrochloride sodium chloride. Its chemical name is: N-methyl-2-pyridineethylamine dihydrochloride. Molecular formula: C8H12N22HC1
Name Description Content CAS NO. Registered Holders
Betahistine dihydrochloride

This product is a diamine oxidase inhibitor, which has a more obvious dilating effect on cerebrovascular and cardiovascular systems, especially on the vertebral artery system, significantly increasing the blood flow of the heart, brain and peripheral circulation, improving blood circulation, and lowering systemic blood pressure. In addition, it can increase the blood flow of the cochlea and anterior base, thereby eliminating inner ear vertigo, tinnitus and ear closure, and can also increase capillary permeability, promote the absorption of extracellular fluid, and eliminate lymphatic edema; it can counteract the vasoconstrictive effect of catecholamines and lower arterial pressure, and has the effect of inhibiting plasma coagulation and ADP-induced platelet aggregation, can prolong the time of thrombosis in vitro in rats, and has a slight diuretic effect.

More

This product is a diamine oxidase inhibitor, which has a more obvious dilating effect on cerebrovascular and cardiovascular systems, especially on the vertebral artery system, significantly increasing the blood flow of the heart, brain and peripheral circulation, improving blood circulation, and lowering systemic blood pressure. In addition, it can increase the blood flow of the cochlea and anterior base, thereby eliminating inner ear vertigo, tinnitus and ear closure, and can also increase capillary permeability, promote the absorption of extracellular fluid, and eliminate lymphatic edema; it can counteract the vasoconstrictive effect of catecholamines and lower arterial pressure, and has the effect of inhibiting plasma coagulation and ADP-induced platelet aggregation, can prolong the time of thrombosis in vitro in rats, and has a slight diuretic effect.

5579-84-0 21
Sodium chloride

This product is a diamine oxidase inhibitor, which has a more obvious dilating effect on cerebrovascular and cardiovascular systems, especially on the vertebral artery system, significantly increasing the blood flow of the heart, brain and peripheral circulation, improving blood circulation, and lowering systemic blood pressure. In addition, it can increase the blood flow of the cochlea and anterior base, thereby eliminating inner ear vertigo, tinnitus and ear closure, and can also increase capillary permeability, promote the absorption of extracellular fluid, and eliminate lymphatic edema; it can counteract the vasoconstrictive effect of catecholamines and lower arterial pressure, and has the effect of inhibiting plasma coagulation and ADP-induced platelet aggregation, can prolong the time of thrombosis in vitro in rats, and has a slight diuretic effect.

More

This product is a diamine oxidase inhibitor, which has a more obvious dilating effect on cerebrovascular and cardiovascular systems, especially on the vertebral artery system, significantly increasing the blood flow of the heart, brain and peripheral circulation, improving blood circulation, and lowering systemic blood pressure. In addition, it can increase the blood flow of the cochlea and anterior base, thereby eliminating inner ear vertigo, tinnitus and ear closure, and can also increase capillary permeability, promote the absorption of extracellular fluid, and eliminate lymphatic edema; it can counteract the vasoconstrictive effect of catecholamines and lower arterial pressure, and has the effect of inhibiting plasma coagulation and ADP-induced platelet aggregation, can prolong the time of thrombosis in vitro in rats, and has a slight diuretic effect.

7647-14-5 43
Clindamycin Hydrochloride and Sodium Chloride Injection
Name Description Content CAS NO. Registered Holders
Clindamycin hydrochloride

21462-39-5 34
Sodium chloride

7647-14-5 43
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.